Bharat Biotech International

With advanced research, we create innovative vaccines and bio-therapeutics for a healthier tomorrow. Bharat Biotech creates innovative vaccines and bio-therapeutics trusted by physicians around the world. We own 160 global patents and our products help people in over 65 countries live to their fullest potential. Our manufacturing facilities are approved by USFDA, KFDA and WHO. We have delivered over 3 billion vaccine doses all over the world. Our key priority is to solve the health challenges of the developing world by developing innovative vaccines and therapeutics. From our early years, we invested in cutting-edge research in areas that need urgent medical solutions. This focus saw a succession of effective vaccines leave our labs and have a lasting impact on the health of millions. Our significant R&D investments have yielded several breakthroughs including the world’s first: Eco-friendly recombinant Hepatitis-B vaccine (free of cesium chloride and Thiomersal). Rotavirus vaccine from a naturally attenuated strain. Typhoid Conjugate vaccine. We have delivered over 3 billion vaccine doses all over the world. REGEN-D® - our epidermal growth factor for diabetic foot ulcers and burns is a leading product in the wound healing segment. Our key priority is to solve the health challenges of the developing world. We were among the first to develop vaccines for viral diseases like Chikungunya and Zika.